These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 26948178)

  • 1. Sofosbuvir antiviral therapy in HCV patients with severe renal failure.
    Rodríguez Gil FJ; Pérez Garrido I
    Gastroenterol Hepatol; 2017 Feb; 40(2):85-86. PubMed ID: 26948178
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of chronic hepatitis C with direct acting antiviral agents in patients with haemophilia, end-stage liver disease and coinfected with HIV.
    Ackens R; Posthouwer D
    Haemophilia; 2016 May; 22(3):e223-5. PubMed ID: 26988201
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection.
    Lin MV; Sise ME; Pavlakis M; Amundsen BM; Chute D; Rutherford AE; Chung RT; Curry MP; Hanifi JM; Gabardi S; Chandraker A; Heher EC; Elias N; Riella LV
    PLoS One; 2016; 11(7):e0158431. PubMed ID: 27415632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B Virus Reactivation During Successful Treatment of Hepatitis C Virus With Sofosbuvir and Simeprevir.
    Collins JM; Raphael KL; Terry C; Cartwright EJ; Pillai A; Anania FA; Farley MM
    Clin Infect Dis; 2015 Oct; 61(8):1304-6. PubMed ID: 26082511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sofosbuvir-based therapy for patients with chronic hepatitis C: Early experience of its efficacy and safety in Korea.
    Cho Y; Cho EJ; Lee JH; Yu SJ; Yoon JH; Kim YJ
    Clin Mol Hepatol; 2015 Dec; 21(4):358-64. PubMed ID: 26770924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sofosbuvir and simeprevir combination therapy in the setting of liver transplantation and hemodialysis.
    Perumpail RB; Wong RJ; Ha LD; Pham EA; Wang U; Luong H; Kumari R; Daugherty TJ; Higgins JP; Younossi ZM; Kim WR; Glenn JS; Ahmed A
    Transpl Infect Dis; 2015 Apr; 17(2):275-8. PubMed ID: 25641426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Full-dose sofosbuvir and daclatasvir for chronic hepatitis C infection in haemodialysis patients.
    Gevers TJ; Burger D; Schipper-Reintjes E; Kooistra MP; Richter C
    Neth J Med; 2016 Jun; 74(5):225-7. PubMed ID: 27323683
    [No Abstract]   [Full Text] [Related]  

  • 8. Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infection.
    Fontana RJ; Brown RS; Moreno-Zamora A; Prieto M; Joshi S; Londoño MC; Herzer K; Chacko KR; Stauber RE; Knop V; Jafri SM; Castells L; Ferenci P; Torti C; Durand CM; Loiacono L; Lionetti R; Bahirwani R; Weiland O; Mubarak A; ElSharkawy AM; Stadler B; Montalbano M; Berg C; Pellicelli AM; Stenmark S; Vekeman F; Ionescu-Ittu R; Emond B; Reddy KR
    Liver Transpl; 2016 Apr; 22(4):446-58. PubMed ID: 26890629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment adherence and virological response rates in hepatitis C virus infected persons treated with sofosbuvir-based regimens: results from ERCHIVES.
    Butt AA; Yan P; Shaikh OS; Chung RT; Sherman KE;
    Liver Int; 2016 Sep; 36(9):1275-83. PubMed ID: 26928927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of sexually acquired acute HCV reinfection with ledipasvir/sofosbuvir in a HIV-infected patient.
    Sollima S; Antinori S; Torre A; Binda F; Giacomelli A; Milazzo L
    Int J STD AIDS; 2017 Jul; 28(8):838-840. PubMed ID: 28632109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic decompensation with sofosbuvir plus simeprevir in a patient with Child-Pugh B compensated cirrhosis.
    Soriano V; Barreiro P; de Mendoza C; Peña JM
    Antivir Ther; 2016; 21(1):91-2. PubMed ID: 26042495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C Virus-Related Hepatic Myelopathy After Treatment With Sofosbuvir and Ribavirin: A Case Report.
    di Biase L; Picillo M; Freitas ME; Bui E; Fasano A
    Ann Intern Med; 2017 Mar; 166(5):379-380. PubMed ID: 28265655
    [No Abstract]   [Full Text] [Related]  

  • 13. Sofosbuvir for treatment of chronic hepatitis C.
    Kattakuzhy S; Levy R; Kottilil S
    Hepatol Int; 2015 Apr; 9(2):161-73. PubMed ID: 25788194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resolution of Atypical Lichen Myxedematosus Following Successful Treatment of Chronic Hepatitis C Virus Infection With Sofosbuvir-Velpatasvir Combination Therapy.
    Jones KM; Shelton ME; Soldano AC; Campbell J
    JAMA Dermatol; 2018 Sep; 154(9):1094-1096. PubMed ID: 30140911
    [No Abstract]   [Full Text] [Related]  

  • 15. Sofosbuvir-based treatment is safe and effective in patients with chronic hepatitis C infection and end stage renal disease: a case series.
    Singh T; Guirguis J; Anthony S; Rivas J; Hanouneh IA; Alkhouri N
    Liver Int; 2016 Jun; 36(6):802-6. PubMed ID: 26824848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial Commentary: Another Call to Cure Hepatitis B.
    Balagopal A; Thio CL
    Clin Infect Dis; 2015 Oct; 61(8):1307-9. PubMed ID: 26082512
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of Sofosbuvir-Based Treatment of Chronic Hepatitis C in Liver Transplant Recipients on Hemodialysis.
    Saab S; A Jimenez M; N Bau S; Choi G; Durazo FA; M El-Kabany M; Han SB; Busuttil RW
    J Clin Gastroenterol; 2017 Feb; 51(2):167-173. PubMed ID: 27548734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Chronic Hepatitis C in Special Populations.
    Bunchorntavakul C; Tanwandee T
    Gastroenterol Clin North Am; 2015 Dec; 44(4):883-900. PubMed ID: 26600226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sofosbuvir and simeprevir in hepatitis C genotype 1-patients with end-stage renal disease on haemodialysis or GFR <30 ml/min.
    Nazario HE; Ndungu M; Modi AA
    Liver Int; 2016 Jun; 36(6):798-801. PubMed ID: 26583882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient with decompensated hepatitis C virus-related cirrhosis delisted for liver transplantation after successful sofosbuvir-based treatment.
    Ruiz I; Feray C; Pawlotsky JM; Hézode C
    Liver Transpl; 2015 Mar; 21(3):408-9. PubMed ID: 25420476
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.